Literature DB >> 18922986

Chronic kidney disease in the United States: a public policy imperative.

Richard A Rettig1, Keith Norris, Allen R Nissenson.   

Abstract

BACKGROUND AND OBJECTIVES: In the past decade, a crisis in nephrology has slowly emerged in the areas of both clinical care and public policy. In 2003, the Council of American Kidney Societies (CAKS) identified 19 barriers to improved patient outcomes in chronic kidney disease (CKD). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Site visits and in-depth telephone interviews were conducted with 15 nephrologists focusing on current issues with identifying and treating patients with CKD. The qualitative analyses were considered in the context of CAKS-identified barriers to assess the present state of nephrology care and provide a foundation for a more detailed quantitative CKD project potential implications for advancing nephrology-related health policy.
RESULTS: Despite new evidence-based therapies to slow, stop, or reverse the progression of CKD to ESRD as well as premature cardiovascular disease, major systemic barriers continue to limit the implementation of this body of evidence at the level of the nephrology practice. Key factors include under- or uninsurance, unstructured medical care systems, and lack of enabling public policies.
CONCLUSIONS: The crisis of nephrology is embedded within the unresolved duress of the ability to provide quality early intervention juxtaposed upon inadequate reimbursement for clinical care and procedures, unfunded mandates for information technology systems, and organizational inconsistencies between nephrology and other specialties. We believe now is the time for the renal community and related stakeholders to unite in an effort to address the clinical, financial, and public policy issues that will enable the delivery of appropriate CKD care to this vulnerable patient population.

Entities:  

Mesh:

Year:  2008        PMID: 18922986     DOI: 10.2215/CJN.02330508

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  17 in total

Review 1.  MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease.

Authors:  Jennifer R Charlton; Scott C Beeman; Kevin M Bennett
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

2.  Relationship Between Age and Timely Placement of Vascular Access In Incident Patients on Hemodialysis.

Authors:  Rubette Harford; Mary Jo Clark; Keith C Norris; Guofen Yan
Journal:  Nephrol Nurs J       Date:  2014 Sep-Oct       Impact factor: 0.959

Review 3.  Socioeconomic disparities in chronic kidney disease.

Authors:  Susanne B Nicholas; Kamyar Kalantar-Zadeh; Keith C Norris
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

4.  The influence of multidisciplinary team clinic on the prognosis of patients with chronic kidney disease.

Authors:  Zhixiang Bian; Qin Zhang; Li Shen; Shunjie Chen
Journal:  Exp Biol Med (Maywood)       Date:  2022-02-24

5.  Relationship Between Age and Pre-End Stage Renal Disease Care in Elderly Patients Treated with Maintenance Hemodialysis.

Authors:  Rubette Harford; Mary Jo Clark; Keith C Norris; Guofen Yan
Journal:  Nephrol Nurs J       Date:  2016 Mar-Apr       Impact factor: 0.959

6.  Translating CKD Research into Primary Care Practice: a Group-Randomized Study.

Authors:  Cara B Litvin; Paul J Nietert; Ruth G Jenkins; Andrea M Wessell; Lynne S Nemeth; Steven M Ornstein
Journal:  J Gen Intern Med       Date:  2019-12-10       Impact factor: 5.128

7.  The association of moderate renal dysfunction with impaired preference-based health-related quality of life: third Korean national health and nutritional examination survey.

Authors:  Hajeong Lee; Yun Jung Oh; Myounghee Kim; Ho Kim; Jung Pyo Lee; Sejoong Kim; Kook-Hwan Oh; Ho Jun Chin; Kwon Wook Joo; Chun Soo Lim; Suhnggwon Kim; Yon Su Kim; Dong Ki Kim
Journal:  BMC Nephrol       Date:  2012-04-24       Impact factor: 2.388

8.  Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study.

Authors:  Alberto Martínez-Castelao; José L Górriz; José M Portolés; Fernando De Alvaro; Aleix Cases; José Luño; Juan F Navarro-González; Rafael Montes; Juan J De la Cruz-Troca; Aparna Natarajan; Daniel Batlle
Journal:  BMC Nephrol       Date:  2011-10-05       Impact factor: 2.388

9.  Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.

Authors:  Eunhee Ji; Yon Su Kim
Journal:  Korean J Intern Med       Date:  2016-03-25       Impact factor: 2.884

10.  The British Columbia Nephrologists' Access Study (BCNAS) - a prospective, health services interventional study to develop waiting time benchmarks and reduce wait times for out-patient nephrology consultations.

Authors:  Michael E Schachter; Alexandra Romann; Ognjenka Djurdev; Adeera Levin; Monica Beaulieu
Journal:  BMC Nephrol       Date:  2013-08-29       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.